|
|
|
| Research progress on the epidemiology of chronic kidney disease |
| ZHU Siyi1, HONG Hang1, BIAN Xueyan2, XU Guozhang1
|
1. School of Public Health, Health Science Center, Ningbo University, Ningbo, Zhejiang 315211, China;
2. The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang 315010, China |
|
|
|
|
Abstract Chronic kidney disease (CKD) is characterized by long course, poor prognosis, multiple complications and high cost of treatment, thus it has become a major public health problem. Based on review of publications pertaining to the epidemiological study of CKD from February 2002 to March 2023, this article summarizes the epidemiological characteristics, risk factors, prevention and control strategies of CKD. It is found that China has the largest number of adult patients with CKD in Asia, and the prevalence of CKD is higher among females and elderly people. The influencing factors for CKD include cardiovascular diseases, diabetes, hypertension and coronavirus disease 2019. Henceforth, it is of vital importance to emphasize three levels of prevention and optimize the CKD management, so as to support for prevention and control of CKD.
|
|
Received: 10 May 2023
Revised: 17 August 2023
Published: 06 September 2023
|
|
|
|
|
|
[1] 上海慢性肾脏病早发现及规范化诊治与示范项目专家组.慢性肾脏病筛查诊断及防治指南[J].中国实用内科杂志,2017,37(1):28-34.
[2] BIKBOV B,PURCELL C,LEVEY A S,et al.Global,regional,and national burden of chronic kidney disease,1990-2017:a systematic analysis for the Global Burden of Disease Study 2017[J].Lancet,2020,395(10225):709-733.
[3] MILLS K T,XU Y,ZHANG W,et al.A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010[J].Kidney Int,2015,88(5):950-957.
[4] LIYANAGE T,TOYAMA T,HOCKHAM C,et al.Prevalence of chronic kidney disease in Asia:a systematic review and analysis[J/OL].BMJ Glob Health,2022,7(1)[2023-08-17].https://doi.org/10.1136/bmjgh-2021-007525.
[5] HOCKHAM C,BAO L,TIKU A,et al.Sex differences in chronic kidney disease prevalence in Asia:a systematic review and meta-analysis[J].Clin Kidney J,2022,15(6):1144-1151.
[6] ZHANG L X,ZHAO M H,ZUO L.China Kidney Disease Network(CK-NET)2016 annual data report[J/OL].Kidney Int Suppl,2020,10(2)[2023-08-17].https://doi.org/10.1016/j.kisu.2020.09.001.
[7] 王善志,朱永俊,唐文庄,等.中国成人及老年人群慢性肾脏病患病率Meta分析[J].中国老年学杂志,2017,37(21): 5384-5388.
[8] United States Renal Data System.2022 USRDS annual data report:epidemiology of kidney disease in the United States[DB/OL].[2023-08-17].https://usrds-adr.niddk.nih.gov/2022/suggested-citation.
[9] HARHAY M N,HARHAY M O,COTO YGLESIAS F,et al.Altitude and regional gradients in chronic kidney disease prevalence in Costa Rica:data from the Costa Rican Longevity and Healthy Aging Study[J].Trop Med Int Health,2016,21(1):41-51.
[10] The UK Kidney Association.UK renal registry 24th annual report - data to 31/12/2020[DB/OL].[2023-08-17].https://ukkidney.org/audit-research/annual-report.
[11] ALICIC R Z,ROONEY M T,TUTTLE K R.Diabetic kidney disease challenges,progress,and possibilities[J].Clin J Am Soc Nephrol,2017,12(12):2032-2045.
[12] HUANG Y M,XU D M,LONG J Y,et al.Spectrum of chronic kidney disease in China:a national study based on hospitalized patients from 2010 to 2015[J].Nephrology,2019,24(7):725-736.
[13] DRAWZ P E,BEDDHU S,KRAMER H J,et al.Blood pressure measurement:a KDOQI perspective[J].Am J Kidney Dis,2020,75(3):426-434.
[14] LEE J Y,PARK J T,JOO Y S,et al.Association of blood pressure with the progression of CKD:findings from KNOW-CKD study[J].Am J Kidney Dis,2021,78(2):236-245.
[15] AGGARWAL R,PETRIE B,BALA W,et al.Mortality outcomes with intensive blood pressure targets in chronic kidney disease patients:a pooled individual patient data analysis from randomized trials[J].Hypertension,2019,73(6):1275-1282.
[16] CHEUNG A K,CHANG T I,CUSHMAN W C,et al.Executive summary of the KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease[J].Kidney Int,2021,99(3):559-569.
[17] SCHMIDT LAUBER C,HANZELMANN S,SCHUNK S,et al.Kidney outcome after mild to moderate COVID-19[J/OL].Nephrol Dial Transplant,2023[2023-08-17].https://doi.org/10.1093/ndt/gfad008.
[18] CHUNG E Y M,PALMER S C,NATALE P,et al.Incidence and outcomes of COVID-19 in people with CKD:a systematic review and meta-analysis[J].Am J Kidney Dis,2021,78(6):804-815.
[19] SANDERS J S F,BEMELMAN F J,MESSCHENDORP A L,et al.The RECOVAC Immune-response Study:the immunogenicity,tolerability,and safety of COVID-19 vaccination in patients with chronic kidney disease,on dialysis,or living with a kidney transplant[J].Transplantation,2022,106(4):821-834.
[20] LEES J S,ELYAN B M P,HERRMANN S M,et al.The“other”big complication:how chronic kidney disease impacts on cancer risks and outcomes[J].Nephrol Dial Transplant,2023,38(5):1071-1079.
[21] BANSAL N,KATZ R,ROBINSON-COHEN C,et al.Absolute rates of heart failure,coronary heart disease,and stroke in chronic kidney disease an analysis of 3 community-based cohort studies[J].JAMA Cardiol,2017,2(3):314-318.
[22] United States Renal Data System.2020 USRDS annual data report:epidemiology of kidney disease in the United States[DB/OL].[2023-08-17].https://usrds-adr.niddk.nih.gov/2020.
[23] ZHANG L,ZHAO M H,ZUO L,et al.China Kidney Disease Network (CK-NET)2015 annual data report[J/OL].Kidney Int Suppl,2019,9[2023-08-17].https://doi.org/10.1016/j.kisu.2018.11.001.
[24] LIN J J, MOREY F,WU H Y,et al.Prevalence and risk factors for chronic kidney disease in Belize:a population-based survey[J/OL].Lancet Reg Health Am,2021[2023-08-17].https://doi.org/10.1016/j.lana.2021.100013.
[25] 鄢佳妮. 慢性肾脏病5期患者发生主要心血管不良事件的危险因素及预后分析[D].重庆:重庆医科大学,2022.
[26] HSU Y H,CHUANG H C,LEE Y H,et al.Traffic-related particulate matter exposure induces nephrotoxicity in vitro and in vivo[J].Free Radic Biol Med,2019,135:235-244.
[27] WU M Y,LO W C,CHAO C T,et al.Association between air pollutants and development of chronic kidney disease:systematic review and meta-analysis[J/OL].Sci Total Environ,2020,706[2023-08-17].https://doi.org/10.1016/j.scitotenv.2019.135522.
[28] 赵剑刚,郑佳琦.PM2.5暴露与肾脏损害的研究进展[J].预防医学,2021,33(5):473-475.
[29] KUMELA GORO K,DESALEGN WOLIDE A,KERGA DIBABA F,et al.Patient awareness,prevalence,and risk factors of chronic kidney disease among diabetes mellitus and hypertensive patients at Jimma University Medical Center,Ethiopia[J/OL].Biomed Res Int,2019[2023-08-17].https://doi.org/10.1155/2019/2383508.
[30] VALLIANOU N G,MITESH S,GKOGKOU A,et al.Chronic kidney disease and cardiovascular disease:is there any relationship?[J].Curr Cardiol Rev,2019,15(1):55-63.
[31] 徐菱忆,惠淼,朱树宏,等.社区慢性肾脏病的筛查与管理现状[J].北京大学学报(医学版),2022,54(5):1056-1063.
[32] BEETHAM K S,KRISHNASAMY R,STANTON T,et al.Effect of a 3-year lifestyle intervention in patients with chronic kidney disease:a randomized clinical trial[J].J Am Soc Nephrol,2022,33(2):431-441.
[33] 王九生,石锦浩,徐波,等.上海市慢性肾脏病三级防治体系优势及推广意义[J].第二军医大学学报,2018,39(1): 24-28.
[34] SCHRAUBEN S J,APPEL L,RIVERA E,et al.Mobile Health(mHealth)technology:assessment of availability,acceptability,and use in CKD[J].Am J Kidney Dis,2021,77(6):941-950.
[35] LAKSHMANAPRABU S K,MOHANTY S N,RANI S S,et al.Online clinical decision support system using optimal deep neural networks[J/OL].Applied Soft Computing,2019,81[2023-08-17].https://doi.org/10.1016/j.asoc.2019.105487. |
|
|
|
